Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04926974 · ClinicalTrials.gov registry record · NA
Community Access Through Remote Eyesight (CARE) Study
A NA study of Low Vision, sponsored by New England College of Optometry.
- Completed
- Registry status
- NA
- Development phase
- 145
- Enrollment target
- 2
- Study locations
NCT04926974 is a NA study of Low Vision that has completed, run by New England College of Optometry. The registered enrollment target is 145 participants, below the 404-participant average among 8 other Low Vision trials with a reported enrollment target (64% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT04926974, a NA study of Low Vision, has completed, sponsored by New England College of Optometry.
- COMPLETED
- Registry status
- NA
- Development phase
- 145 participants
- Enrollment target
- 2
- Study locations
Study Summary
Study is a randomized clinical trial evaluating the efficacy of novel mobile application technologies (including Seeing AI, Aira, and Supervision+) to improve quality of life in older adults with low vision by expanding community access and providing assistance with activities of daily living. Aira provides real-time remote personal assistance through a sighted Aira agent supplying direct feedback to assist with visual tasks. Seeing AI provides optical character recognition allowing any text to be read aloud, color identification, bar code reading, scene description, and facial recognition based on stored photos. Supervision + allows one to use the phone as a magnifier, providing magnification and contrast enhancement using the camera of the mobile phone. This study seeks to understand the potential of these technologies to improve daily activities, community participation, independence, and self-sufficiency in this group by examining a technological approach, which has not yet undergone rigorous investigation in a diverse population of older adults with visual impairment. Project objectives are to evaluate mobile applications in a wide range of visual disability, categorized into three groups: (1) mild to moderate visual acuity loss, (2) severe to profound visual acuity loss, and (3) legal blindness secondary to visual field loss. Participants are randomized to one of three intervention groups: (1) Supervision+ application, (2) Aira application, or (3) Seeing AI application for a period of 6 months. For the Aira intervention group, participants will be assigned either with 'restricted' access (current open access areas plus 30 minutes/month anywhere), or 'unrestricted' access (700 minutes), for a period of 3 months with a 3 month cross-over period. Participants may elect to continue the study for an additional 3 months during which time they have access to all 3 study mobile applications. Outcome measures include assessment of changes at three, six and nine months
Conditions Studied
Interventions
- BEHAVIORAL Low Vision Rehabilitation
Study Locations (2)
California
- UCLA Stein Eye Institute - Los Angeles
Massachusetts
- New England College of Optometry - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2021-06-02 |
| Est. Completion | 2023-09-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04926974
The ClinicalTrials.gov registry entry for NCT04926974 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 404-participant average among 8 other Low Vision trials with a reported enrollment target (64% lower). The listed sponsor is New England College of Optometry, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Low Vision appearing as the primary indexed condition, and to 1 intervention - of which Low Vision Rehabilitation is the first listed.
NCT04926974 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04926974 about?
NCT04926974 is a clinical study titled "Community Access Through Remote Eyesight (CARE) Study". Study is a randomized clinical trial evaluating the efficacy of novel mobile application technologies (including Seeing AI, Aira, and Supervision+) to improve quality of life in older adults with low vision by expanding community access and providing assistance with activities of daily living. Aira ...
What is the current status of trial NCT04926974?
This trial is currently completed. It is a NA study. The enrollment target is 145 participants. The study started on 2021-06-02. Estimated completion is 2023-09-29.
What conditions does trial NCT04926974 study?
This clinical trial studies the following conditions: Low Vision.
What interventions are being tested in trial NCT04926974?
The interventions under investigation include: Low Vision Rehabilitation (BEHAVIORAL).
Who is sponsoring clinical trial NCT04926974?
This trial is sponsored by New England College of Optometry, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04926974 being conducted?
This trial has 2 study locations across California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Low Vision
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Beacon Sensors and Telerehabilitation to Assess and Improve Use of Devices (BeST-AID) for Low Vision
RECRUITING · NA
-
Wearable Echolocation Aids Using Parametric Sound
RECRUITING · NA
-
Obstacle Negotiation in Older People With and Without Vision Impairment
RECRUITING · NA
-
SmartHMD for Improved Mobility
COMPLETED · NA
-
Socially Assistive Robots to Enhance Magnification Device Use for Reading
RECRUITING · Phase 1
-
A Study of Interventions to Reduce Disability From Visual Loss in Nursing Home Residents
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.